FilingReader Intelligence
Shengda Bio-pharm shareholder equity changes announced
February 18, 2025 at 07:49 AM UTC•By FilingReader AI
Zhejiang Shengda Bio-pharm (SSE:603079) announced a change in shareholder equity stemming from Tianjin Wanjian Investment Development Center (Tianjin Wanjian) reducing its stake. This action aligns with Tianjin Wanjian’s previously disclosed plans to reduce holdings. The collective holdings of Tianjin Wanjian and its entities now total 55.00% of Shengda Bio-pharm's total share capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:603079•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Zhejiang Shengda Bio-pharm publishes news
Free account required • Unsubscribe anytime